Haplotype-based case-control study of the human AGTR1 gene and essential hypertension in Han Chinese subjects

Clinical Biochemistry

Volumn 43, Issue 3, 2010, Pages 253-258

  Nie, Sheng jie ^a,b   Wen ru, Tang ^a,c   Bi feng, Chen ^a   Jin, Li ^a,d   Wen, Zhang ^a   Sheng jun, Luo ^a   Wei wei, Li ^a   Hai jing, Yu ^a   Chun jie, Xiao ^a  

^a YUNNAN UNIVERSITY   (China)

^b KUNMING MEDICAL UNIVERSITY   (China)

^c KUNMING UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^d YUNNAN NORMAL UNIVERSITY   (China)

Author keywords

AGTR1; Association study; Essential hypertension; Haplotypes; Single nucleotide polymorphism; tag SNP

Indexed keywords

ADENOSINE; ANGIOTENSIN 1 RECEPTOR; CYTIDINE; GUANOSINE; THYMIDINE;

ADULT; ARTICLE; CHINESE; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HIGH RISK POPULATION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; CASE-CONTROL STUDIES; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTOR, ANGIOTENSIN, TYPE 1;

EID: 74249114794     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2009.09.027     Document Type: Article

References (38)

1. Lifton R.P., Gharavi A.G., and Geller D.S. Molecular mechanisms of human hypertension. Cell 104 (2001) 545-556
2. Marteau J.B., Zaiou M., Siest G., and Visvikis-Siest S. Genetic determinants of blood pressure regulation. J. Hypertens. 23 (2005) 2127-2143
3. Suchankova P., Henningsson S., Olsson M., et al. Association between the AGTR1 polymorphism +1166A>C and serum levels of high-sensitivity C-reactive protein. Regul. Pept. 152 (2009) 28-32
4. Davies E., Bonnardeaux A., Plouin P.F., Corvol P., and Clauser E. Somatic mutations of the angiotensin II (AT1) receptor gene are not present in aldosterone-producing adenoma. J. Clin. Endocrinol. Metab. 82 (1997) 611-615
5. van Geel P.P., Pinto Y.M., Voors A.A., et al. Angiotensin II type 1 receptor A1166C gene polymorphism is associated with an increased response to angiotensin II in human arteries. Hypertension 35 (2000) 717-721
6. Su S., Chen J., Zhao J., et al. Angiotensin II type I receptor gene and myocardial infarction: tagging SNPs and haplotype based association study. The Beijing atherosclerosis study. Pharmacogenetics 14 (2004) 673-681
7. Guo D.F., Furuta H., Mizukoshi M., and Inagami T. The genomic organization of human angiotensin II type 1 receptor. Biochem. Biophys. Res. Commun. 200 (1994) 313-319
8. Mottl A.K., Shoham D.A., and North K.E. Angiotensin II type 1 receptor polymorphisms and susceptibility to hypertension: a HuGE review. Genet. Med. 10 (2008) 560-574
9. Kikuya M., Sugimoto K., Katsuya T., et al. A/C1166 gene polymorphism of the angiotensin II type 1 receptor (AT1) and ambulatory blood pressure: the Ohasama Study. Hypertens. Res. 26 (2003) 141-145
10. Palatini P., Ceolotto G., Dorigatti F., et al. Angiotensin II type 1 receptor gene polymorphism predicts development of hypertension and metabolic syndrome. Am. J. Hypertens. 22 (2009) 208-214
11. Zhu S., and Meng Q.H. Association of angiotensin II type 1 receptor gene polymorphism with carotid atherosclerosis. Clin. Chem. Lab. Med. 44 (2006) 282-284
12. Jiang X., Sheng H., Li J., et al. Association between renin-angiotensin system gene polymorphism and essential hypertension: a community-based study. J. Hum. Hypertens. 23 (2009) 176-181
13. Martin E.R., Lai E.H., Gilbert J.R., et al. SNPing away at complex diseases: analysis of single-nucleotide polymorphisms around APOE in Alzheimer disease. Am. J. Hum. Genet. 67 (2000) 383-394
14. Shi Y.Y., and He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell. Res. 15 (2005) 97-98
15. Zhang K., Qin Z.S., Liu J.S., Chen T., Waterman M.S., and Sun F. Haplotype block partitioning and tag SNP selection using genotype data and their applications to association studies. Genome Res. 14 (2004) 908-916
16. Gavras H., Lever A.F., Brown J.J., Macadam R.F., and Robertson J.I. Acute renal failure, tubular necrosis, and myocardial infarction induced in the rabbit by intravenous angiotensin II. Lancet 2 (1971) 19-22
17. Brunner H.R. Experimental and clinical evidence that angiotensin II is an independent risk factor for cardiovascular disease. Am. J. Cardiol. 87 (2001) 3C-9C
18. Mazzolai L., Pedrazzini T., Nicoud F., Gabbiani G., Brunner H.R., and Nussberger J. Increased cardiac angiotensin II levels induce right and left ventricular hypertrophy in normotensive mice. Hypertension 35 (2000) 985-991
19. Devereux R.B., Dahlof B., Gerdts E., et al. Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial. Circulation 110 (2004) 1456-1462
20. Crowley S.D., Gurley S.B., Herrera M.J., et al. Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 17985-17990
21. Crowley S.D., Tharaux P.L., Audoly L.P., and Coffman T.M. Exploring type I angiotensin (AT1) receptor functions through gene targeting. Acta Physiol. Scand. 181 (2004) 561-570
22. Ito M., Oliverio M.I., Mannon P.J., et al. Regulation of blood pressure by the type 1A angiotensin II receptor gene. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 3521-3525
23. Le T.H., Kim H.S., Allen A.M., Spurney R.F., Smithies O., and Coffman T.M. Physiological impact of increased expression of the AT1 angiotensin receptor. Hypertension 42 (2003) 507-514
24. Bonnardeaux A., Davies E., Jeunemaitre X., et al. Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension 24 (1994) 63-69
25. Hilgers K.F., Langenfeld M.R., Schlaich M., Veelken R., and Schmieder R.E. 1166 A/C polymorphism of the angiotensin II type 1 receptor gene and the response to short-term infusion of angiotensin II. Circulation 100 (1999) 1394-1399
26. Kainulainen K., Perola M., Terwilliger J., et al. Evidence for involvement of the type 1 angiotensin II receptor locus in essential hypertension. Hypertension 33 (1999) 844-849
27. Tiret L., Blanc H., Ruidavets J.B., et al. Gene polymorphisms of the renin-angiotensin system in relation to hypertension and parental history of myocardial infarction and stroke: the PEGASE study. Projet d'Etude des Genes de l'Hypertension Arterielle Severe a moderee Essentielle. J. Hypertens. 16 (1998) 37-44
28. Niu W.Q., Zhao H.Y., Zhou L., et al. Interacting effect of genetic variants of angiotensin II type 1 receptor on susceptibility to essential hypertension in Northern Han Chinese. J. Hum. Hypertens. 23 (2009) 68-71
29. Erdmann J., Riedel K., Rohde K., et al. Characterization of polymorphisms in the promoter of the human angiotensin II subtype 1 (AT1) receptor gene. Ann. Hum. Genet. 63 (1999) 369-374
30. Jiang Z., Zhao W., Yu F., and Xu G. Association of angiotensin II type 1 receptor gene polymorphism with essential hypertension. Chin. Med. J. (Engl.) 114 (2001) 1249-1251
31. Liyou N., Davis D., James K., et al. The A1166C mutation in the angiotensin II type I receptor and hypertension in the elderly. Clin. Exp. Pharmacol. Physiol. 26 (1999) 525-526
32. Thomas G.N., Tomlinson B., Chan J.C., Sanderson J.E., Cockram C.S., and Critchley J.A. Renin-angiotensin system gene polymorphisms, blood pressure, dyslipidemia, and diabetes in Hong Kong Chinese: a significant association of tne ACE insertion/deletion polymorphism with type 2 diabetes. Diabet. Care 24 (2001) 356-361
33. Bautista L.E., Vargas C.I., Orostegui M., and Gamarra G. Population-based case-control study of renin-angiotensin system genes polymorphisms and hypertension among Hispanics. Hypertens. Res. 31 (2008) 401-408
34. Lapierre A.V., Arce M.E., Lopez J.R., Ciuffo G.M., and Angiotensin I.I. type 1 receptor A1166C gene polymorphism and essential hypertension in San Luis. Biocell 30 (2006) 447-455
35. Halperin E., Kimmel G., and Shamir R. Tag SNP selection in genotype data for maximizing SNP prediction accuracy. Bioinformatics 21 Suppl 1 (2005) i195-i1203
36. Yoshikawa Y., Nakayama T., Saito K., et al. Haplotype-based case-control study of the association between the guanylate cyclase activator 2B (GUCA2B, Uroguanylin) gene and essential hypertension. Hypertens. Res. 30 (2007) 789-796
37. Zhang K., Calabrese P., Nordborg M., and Sun F. Haplotype block structure and its applications to association studies: power and study designs. Am. J. Hum. Genet. 71 (2002) 1386-1394
38. Johnson G.C., Esposito L., Barratt B.J., et al. Haplotype tagging for the identification of common disease genes. Nat. Genet. 29 (2001) 233-237